Jurickson Profar Suspended 162 Games for PED Violation

Major League Baseball (MLB) has suspended Atlanta Braves outfielder Jurickson Profar for 162 games after he tested positive for exogenous testosterone, a banned performance-enhancing drug. The suspension, effective this Friday, will sideline Profar for the entire 2026 season, including any potential postseason appearances. This marks the second PED-related suspension in Profar’s career, as he missed 80 games last year following a positive test for Chorionic Gonadotropin.

Players Association Prepares to Challenge the Suspension

According to reports from Ken Rosenthal of The Athletic, the MLB Players Association intends to file a grievance disputing the 162-game suspension. Typically, MLB delays public announcements about PED violations until after the appeals process concludes, allowing players to continue competing during that time. However, Profar’s penalty is not stayed this time due to it being his second offense, meaning he cannot play while the appeal is unsettled. The league is working to expedite the review to reach a swift final decision.

Financial and Competitive Consequences for Profar

If the suspension is upheld, Profar will forfeit his $15 million salary for the coming season. Additionally, as a Curacao native, Profar will be ineligible to compete for the Netherlands in the World Baseball Classic. The Braves organization expressed strong disappointment over the situation in an official statement:

“We were incredibly disappointed to learn that Jurickson tested positive for a performance-enhancing substance and is in violation of MLB’s Drug Prevention and Treatment Program,”

the team said.

“Our players are consistently educated about the Program and the consequences if they are found to be in violation.”

Contract Status and Career Trajectory

Profar, who recently turned 33, was entering the second year of a three-year, $42 million contract with Atlanta. Last year’s 80-game suspension cost him nearly $6 million of his $12 million salary for the first season of this deal. He remains signed with the Braves through 2027 and was scheduled to earn another $15 million in the contract’s final year. Notably, a third positive PED test would trigger a lifetime ban from MLB.

Early Promise and Injury Setbacks Mark Career

As a teenager, Profar was regarded as the sport’s top prospect, a switch-hitting shortstop with exceptional power, speed, and defensive skills. His career, however, was hindered by multiple shoulder injuries, causing him to miss almost all games in 2014 and 2015 due to surgery. Upon his return, his performance and defensive reliability shifted; from 2016 to 2017, he posted a disappointing batting line in 377 plate appearances and his shoulder issues forced a move from shortstop to second and first base. Subsequently, he was traded to the Oakland Athletics, but spent only one underwhelming year there before moving on to the San Diego Padres.

Fluctuating Performance and Team Changes

Profar’s tenure with the Padres included an inconsistent start to the shortened 2020 season, though he managed a strong finish during the 60-game schedule. Padres General Manager A.J. Preller, who originally signed Profar as an international amateur during his time with the Texas Rangers, valued him enough to offer a three-year contract after the season. Despite this, Profar struggled in the first year of that deal, batting .227/.329/.320. He declined an opt-out option, returned for the 2022 campaign with improved hitting, and later opted out to re-enter free agency. However, interest from teams was limited that winter.

Recent Contracts and Resurgence Before Suspension

Before the 2023 season, Profar signed a $7.75 million contract with the Colorado Rockies but was released after batting .236/.316/.364 over 111 games. He returned to the Padres for the remainder of the season and showed promise in a small sample of 14 games. A slow free agency period followed until San Diego signed him again for a one-year, $1 million deal. This low-cost contract turned into a bargain as Profar responded with career-best offensive numbers, hitting .280/.380/.459. This resurgence led to the Braves offering him the lucrative three-year, $42 million agreement prior to the suspension announcement.

Impact of Suspension on Braves Roster and Finances

Profar’s suspension raises questions about his future with the Braves, especially after missing 80 games last year and now facing a year-long absence beginning immediately. He will be placed on the restricted list, which means he will not receive salary and will not count against the 40-man roster. This move will save Atlanta his $15 million salary plus the 20% luxury tax they would have paid, totaling approximately $18 million in savings. This unexpected financial flexibility could allow the Braves to pursue additional roster reinforcements during the offseason.

Rotation Injuries Create Additional Challenges for Atlanta

The Braves’ pitching staff is currently dealing with injuries to key right-handed starters Spencer Schwellenbach and Hurston Waldrep, both of whom have undergone elbow surgeries and face uncertain recovery timelines. Schwellenbach is already placed on the 60-day injured list, with Waldrep expected to follow. This leaves the club’s top rotation spots primarily occupied by Chris Sale, Spencer Strider, Reynaldo Lopez—who made just one start last season after shoulder surgery—and Grant Holmes, who is rehabbing a UCL tear without surgery. Other options include Bryce Elder, Joey Wentz, Didier Fuentes, and Jose Suarez.

Free Agent Market Remains Open for Veterans and Pitchers

Several veteran pitchers such as Lucas Giolito, Zack Littell, and Tyler Anderson remain unsigned in free agency. With the uncertainty in the rotation and the suspension impact, the Braves front office may pursue these or other players to reinforce the pitching depth. Meanwhile, the outfield group has also been weakened by Profar’s absence despite the offseason acquisition of Mike Yastrzemski. Along with Michael Harris II and Ronald Acuña Jr., Yastrzemski forms the core of the starting outfield, although injury concerns and platoon splits add complexity. Additional outfield candidates like Eli White and Jorge Mateo offer limited success against left-handed pitching.

Financial Implications and Potential Moves Ahead

Even after these adjustments, Atlanta is expected to remain just above the $244 million luxury tax threshold. The salary relief from Profar’s suspension grants the Braves new ammunition for pursuing midseason reinforcements or late off-season acquisitions, possibly including a veteran bat or another starting pitcher. How the team deploys this unexpected flexibility will be a key storyline as they navigate the months leading to spring training and beyond.